AKTS
Akoustis Technologies Inc

3,052
Mkt Cap
$1.1B
Volume
432,303.00
52W High
$29.16
52W Low
$0.0372
Price
$19.92
AKTS Fundamentals
Prev Close
$20.90
Open
$20.90
50D MA
$19.78
Beta
0.00
Avg. Volume
494,614.31
EPS (Annual)
-$0.8374
P/B
-11.92
Loading...
Loading...
News
all
press releases
Aktis Oncology (NASDAQ:AKTS) Coverage Initiated at TD Cowen
TD Cowen started coverage on shares of Aktis Oncology in a report on Tuesday. They issued a "buy" rating for the company...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Now Covered by Bank of America
Bank of America began coverage on Aktis Oncology in a research report on Tuesday. They issued a "buy" rating and a $34.00 price target on the stock...
MarketBeat·2d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Now Covered by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. began coverage on Aktis Oncology in a research note on Tuesday. They issued an "overweight" rating and a $30.00 target price on the stock...
MarketBeat·2d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Earns Outperform Rating from Analysts at Leerink Partners
Leerink Partners assumed coverage on shares of Aktis Oncology in a report on Tuesday. They set an "outperform" rating and a $31.00 price objective on the stock...
MarketBeat·2d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Shares Down 7.1% - Here's What Happened
Aktis Oncology (NASDAQ:AKTS) Stock Price Down 7.1% - Here's Why...
MarketBeat·13d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Stock Price Up 12.3% - Still a Buy?
Aktis Oncology (NASDAQ:AKTS) Trading 12.3% Higher - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Reaches New 1-Year Low - Should You Sell?
Aktis Oncology (NASDAQ:AKTS) Sets New 12-Month Low - Should You Sell...
MarketBeat·15d ago
<
...
1
>

Latest AKTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.